In the late afternoon at the first day of the Global Congress Combating Counterfeiting and Piracy, a Boardroom Dialogue Session was held on “IP enforcement and sustainable development – perspectives and challenges.” Johannes Christian Wichard, Deputy Director General of WIPO’s…
The afternoon at the Global Congress Combating Counterfeiting and Piracy included two sets of Boardroom Dialogue Discussions. In the first set, one was “Competition law and building respect for IP.” It was moderated by Josef Drexl, Director of the Max-Planck-Institut…
After the opening plenary of the Global Congress Combating Counterfeiting and Piracy, the conference split into two simultaneous Boardroom Dialogue Sessions, including one on “Determining the Impact – the Importance of Measuring the Scope and Impact of Infringement.” It was…
The opening of the Global Congress Combating Counterfeiting and Piracy featured the heads of many different public and private organizations. The themes that were repeated by all speakers were 1) the need to convince the public to have a greater…
Stichting Bescherming Rechten Entertainment Industrie Nederland (BREIN) announced that it and the Motion Picture Association of America (MPAA) convinced hosting companies to take down 51 torrent sites in January. Last year, BREIN says they won the takedown of over 600…
On January 18, the Advisory Committee to the Congressional Internet Caucus held the Seventh Annual State of the Net Conference to discuss current issues and upcoming legislation in 2011. The event brought together industry groups, consumer groups, and government officials…
The Advisory Committee to the Congressional Internet Caucus is holding its 2011 “State of the Net Conference” on January 18 and 19 in Washington, D.C. The industry-sponsored event will include keynote addresses by Representatives Blackburn and Goodlatte, Department of Commerce…
IP Watch on January 25 published GlaxoSmithKline’s position statement on the Anti-Counterfeiting Trade Agreement. The company generally supports the agreement, as it “fully supports any efforts aimed at ensuring strong enforcement of IPRs.” GSK would have preferred to have seen…